View in EDS HTML Full Text PDF Full Text

Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.

Saved in:
Bibliographic Details
Title: Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
Authors: McInnes N; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Hall S; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada., Lochnan HA; Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Harris SB; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Punthakee Z; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada., Sigal RJ; Departments of Medicine, Cardiac Sciences and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Hramiak I; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Azharuddin M; LMC Diabetes and Endocrinology, Burlington, Ontario, Canada., Liutkus JF; JF Liutkus Medicine Professional Corporation, Cambridge, Ontario, Canada., Yale JF; McGill University, Quebec, Canada., Sultan F; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Smith A; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Otto RE; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Sherifali D; School of Nursing, McMaster University, Hamilton, Ontario, Canada., Liu YY; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada., Gerstein HC; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Corporate Authors: REMIT-iGlarLixi Collaborative Group
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Nov; Vol. 25 (11), pp. 3347-3355. Date of Electronic Publication: 2023 Aug 14.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37580972
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McInnes+N%22">McInnes N</searchLink>; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hall+S%22">Hall S</searchLink>; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Lochnan+HA%22">Lochnan HA</searchLink>; Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Harris+SB%22">Harris SB</searchLink>; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Punthakee+Z%22">Punthakee Z</searchLink>; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Sigal+RJ%22">Sigal RJ</searchLink>; Departments of Medicine, Cardiac Sciences and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Hramiak+I%22">Hramiak I</searchLink>; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Azharuddin+M%22">Azharuddin M</searchLink>; LMC Diabetes and Endocrinology, Burlington, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Liutkus+JF%22">Liutkus JF</searchLink>; JF Liutkus Medicine Professional Corporation, Cambridge, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yale+JF%22">Yale JF</searchLink>; McGill University, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Sultan+F%22">Sultan F</searchLink>; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Smith+A%22">Smith A</searchLink>; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Otto+RE%22">Otto RE</searchLink>; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Sherifali+D%22">Sherifali D</searchLink>; School of Nursing, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Liu+YY%22">Liu YY</searchLink>; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Gerstein+HC%22">Gerstein HC</searchLink>; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22REMIT-iGlarLixi+Collaborative+Group%22">REMIT-iGlarLixi Collaborative Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2023 Nov; Vol. 25 (11), pp. 3347-3355. <i>Date of Electronic Publication: </i>2023 Aug 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37580972
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/dom.15234
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3347
    Titles:
      – TitleFull: Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McInnes N
      – PersonEntity:
          Name:
            NameFull: Hall S
      – PersonEntity:
          Name:
            NameFull: Lochnan HA
      – PersonEntity:
          Name:
            NameFull: Harris SB
      – PersonEntity:
          Name:
            NameFull: Punthakee Z
      – PersonEntity:
          Name:
            NameFull: Sigal RJ
      – PersonEntity:
          Name:
            NameFull: Hramiak I
      – PersonEntity:
          Name:
            NameFull: Azharuddin M
      – PersonEntity:
          Name:
            NameFull: Liutkus JF
      – PersonEntity:
          Name:
            NameFull: Yale JF
      – PersonEntity:
          Name:
            NameFull: Sultan F
      – PersonEntity:
          Name:
            NameFull: Smith A
      – PersonEntity:
          Name:
            NameFull: Otto RE
      – PersonEntity:
          Name:
            NameFull: Sherifali D
      – PersonEntity:
          Name:
            NameFull: Liu YY
      – PersonEntity:
          Name:
            NameFull: Gerstein HC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1463-1326
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Diabetes, obesity & metabolism
              Type: main
ResultId 1